Cellular morphometry in late-life depression: A review of postmortem studies

American Journal of Geriatric Psychiatry

Volumn 22, Issue 2, 2014, Pages 122-132

  Khundakar, Ahmad A ^a   Thomas, Alan J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Depression; Disector; Late life; Morphometry; Neuropathology; Postmortem

Indexed keywords

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; AUTOPSY; BRAIN REGION; CAUDATE NUCLEUS; CELL DENSITY; COGNITION; CORPUS STRIATUM; DENTATE GYRUS; DEPRESSION; DORSAL RAPHE NUCLEUS; ENTORHINAL CORTEX; GLIA CELL; GLOBUS PALLIDUS; HUMAN; LATE LIFE DEPRESSION; MAJOR DEPRESSION; MENTAL STRESS; MOOD DISORDER; MORPHOMETRICS; NERVE CELL; NEUROBIOLOGY; NEUROIMAGING; ORBITAL CORTEX; PREFRONTAL CORTEX; SUBSTANTIA NIGRA; TEGMENTUM; TEMPORAL CORTEX; THALAMUS; WHITE MATTER; WHITE MATTER LESION;

DEPRESSION; DISECTOR; LATE LIFE; MORPHOMETRY; NEUROPATHOLOGY; POSTMORTEM;

AGE OF ONSET; BRAIN; CELL COUNT; DEPRESSION; HUMANS; MODELS, NEUROLOGICAL; NEUROGLIA; NEUROIMAGING; NEURONS;

EID: 84893026227     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2013.06.003     Document Type: Article

References (95)

1. Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3:e442
2. Alexopoulos GS, Vrontou C, Kakuma T, et al: Disability in geriatric depression. Am J Psychiatry 1996; 153:877-885
3. Beekman AT, Deeg DJ, Braam AW, et al: Consequences of major and minor depression in later life: a study of disability, well-being and service utilization. Psychol Med 1997; 27:1397-1409
4. Harris T, Cook DG, Victor C, et al: Onset and persistence of depression in older people-results from a 2-year community follow-up study. Age Ageing 2006; 35:25-32
5. Katon WJ, Lin E, Russo J, et al: Increased medical costs of a population-based sample of depressed elderly patients. Arch Gen Psychiatry 2003; 60:897-903
6. Dew MA, Whyte EM, Lenze EJ, et al: Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry 2007; 164:892-899
7. Whyte EM, Basinski J, Farhi P, et al: Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry 2004; 65:1634-1641
8. Whyte EM, Dew MA, Gildengers A, et al: Time course of response to antidepressants in late-life major depression: therapeutic implications. Drugs Aging 2004; 21:531-554
9. Sneed JR, Roose SP, Sackeim HA: Vascular depression: a distinct diagnostic subtype? Biol Psychiatry 2006; 60:1295-1298
10. Sneed JR, Culang-Reinlieb ME: The vascular depression hypothesis: an update. Am J Geriatr Psychiatry 2011; 19:99-103
11. Lyness JM, Niculescu A, Tu X, et al: The relationship of medical comorbidity and depression in older, primary care patients. Psychosomatics 2006; 47:435-439
12. Baldwin RC, O'Brien J: Vascular basis of late-onset depressive disorder. Br J Psychiatry 2002; 180:157-160
13. Alexopoulos GS, Meyers BS, Young RC, et al: Clinically defined vascular depression. Am J Psychiatry 1997; 154:562-565
14. Krishnan KR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry 1997; 154:497-501
15. Sheline YI, Pieper CF, Barch DM, et al: Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 2010; 67:277-285
16. Krishnan MS, O'Brien JT, Firbank MJ, et al: Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study. Int J Geriatr Psychiatry 2006; 21:983-989
17. O'Brien J, Desmond P, Ames D, et al: A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br J Psychiatry 1996; 168:477-485
18. Sheline YI, Price JL, Vaishnavi SN, et al: Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry 2008; 165:524-532
19. Herrmann LL, Le Masurier M, Ebmeier KP: White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry 2008; 79:619-624
20. Teodorczuk A, O'Brien JT, Firbank MJ, et al: White matter changes and late life depressive symptoms: longitudinal study. Br J Psychiatry 2007; 191:212-217
21. Herman JP, Cullinan WE, Morano MI, et al: Contribution of the ventral subiculum to inhibitory regulation of the hypothalamopituitary-adrenocortical axis. J Neuroendocrinol 1995; 7:475-482
22. Steffens DC, Helms MJ, Krishnan KR, et al: Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke 1999; 30:2159-2166
23. de Groot JC, de Leeuw FE, Oudkerk M, et al: Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry 2000; 57:1071-1076
24. Sexton CE, Mackay CE, Ebmeier KP: A systematic review and meta-analysis of magnetic resonance imaging studies in late-life depression. Am J Geriatr Psychiatry 2013; 21:184-195
25. Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9:357-381
26. Bonelli RM, Cummings JL: Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci 2007; 9:141-151
27. Vogt BA, Finch DM, Olson CR: Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex 1992; 2:435-443
28. Drevets WC, Bogers W, Raichle ME: Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 2002; 12:527-544
29. Drevets WC, Price JL, Furey ML: Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008; 213:93-118
30. Hercher C, Turecki G, Mechawar N: Through the looking glass: examining neuroanatomical evidence for cellular alterations in major depression. J Psychiatr Res 2009; 43:947-961
31. Middleton FA, Strick PL: Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn 2000; 42:183-200
32. Bunge SA, Klingberg T, Jacobsen RB, et al: A resource model of the neural basis of executive working memory. Proc Natl Acad Sci USA 2000; 97:3573-3578
33. Kringelbach ML: The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci 2005; 6:691-702
34. Tekin S, Cummings JL: Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002; 53: 647-654
35. Mega MS, Cummings JL, Salloway S, et al: The limbic system: an anatomic, phylogenetic, and clinical perspective. J Neuropsychiatry Clin Neurosci 1997; 9:315-330
36. Gundersen HJ: The nucleator. J Microsc 1988; 151:3-21
37. Tandrup T, Gundersen HJ, Jensen EB: The optical rotator. J Microsc 1997; 186:108-120
38. Khundakar AA, Thomas AJ: The possible applications (and pitfalls!) of stereological analysis in postmortem brain research, in Neurostereology. Edited by Mouton PR. Hoboken, NJ, Wiley, in press
39. Bowley MP, Drevets WC, Ongur D, et al: Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 2002; 52: 404-412
40. Khundakar A, Morris C, Oakley A, et al: A morphometric examination of neuronal and glial cell pathology in the orbitofrontal cortex in late-life depression. International Psychogeriatrics 2011; 23:132-140
41. Khundakar A, Morris C, Oakley A, et al: Morphometric analysis of neuronal and glial cell pathology in the caudate nucleus in latelife depression. Am J Geriatr Psychiatry 2011; 19:132-141
42. Khundakar AA, Morris CM, Oakley AE, et al: Morphometric analysis of neuronal and glial cell pathology in the dorsolateral prefrontal cortex in late-life depression. Br J Psychiatry 2009; 195: 163-169
43. Khundakar AA, Morris CM, Oakley AE, et al: Cellular pathology within the anterior cingulate cortex of patients with late-life depression: a morphometric study. Psychiatry Res 2011; 194(2): 184-189
44. Rajkowska G, Miguel-Hidalgo JJ, Dubey P, et al: Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biol Psychiatry 2005; 58: 297-306
45. Van Otterloo E, O'Dwyer G, Stockmeier CA, et al: Reductions in neuronal density in elderly depressed are region specific. Int J Geriatr Psychiatry 2009; 24:856-864
46. Ongur D, Drevets WC, Price JL: Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95:13290-13295
47. Cotter D, Hudson L, Landau S: Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia. Bipolar Disord 2005; 7:358-369
48. Cotter D, Mackay D, Landau S, et al: Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001; 58:545-553
49. Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al: Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45:1085-1098
50. Cobb JA, Simpson J, Mahajan GJ, et al: Hippocampal volume and total cell numbers in major depressive disorder. J Psychiatr Res 2013; 47:299-306
51. Stockmeier CA, Mahajan GJ, Konick LC, et al: Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 2004; 56:640-650
52. Young KA, Holcomb LA, Yazdani U, et al: Elevated neuron number in the limbic thalamus in major depression. Am J Psychiatry 2004; 161:1270-1277
53. Manaye KF, Lei DL, Tizabi Y, et al: Selective neuron loss in the paraventricular nucleus of hypothalamus in patients suffering from major depression and bipolar disorder. J Neuropathol Exp Neurol 2005; 64:224-229
54. Boldrini M, Santiago AN, Hen R, et al: Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression. Neuropsychopharmacology 2013; 38: 1068-1077
55. Uranova NA, Vostrikov VM, Orlovskaya DD, et al: Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 2004; 67:269-275
56. Vostrikov VM, Uranova NA, Orlovskaya DD: Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophr Res 2007; 94:273-280
57. Miguel-Hidalgo JJ, Baucom C, Dilley G, et al: Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry 2000; 48:861-873
58. Davis S, Thomas A, Perry R, et al: Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study. J Neurol Neurosurg Psychiatry 2002; 73:556-560
59. Si X, Miguel-Hidalgo JJ, O'Dwyer G, et al: Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology 2004; 29:2088-2096
60. Cotter DR, Pariante CM, Everall IP: Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 2001; 55:585-595
61. Rajkowska G, Miguel-Hidalgo JJ: Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 2007; 6:219-233
62. Khundakar AA, Thomas AJ: Morphometric changes in early-and late-life major depressive disorder: evidence from postmortem studies. Int Psychogeriatr 2009; 21:844-854
63. Hickie IB, Naismith SL, Norrie LM, et al: Managing depression across the life cycle: new strategies for clinicians and their patients. Intern Med J 2009; 39:720-727
64. Hickie IB, Rogers NL: Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet 2011; 378: 621-631
65. Berman RM, Cappiello A, Anand A, et al: Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47:351-354
66. Zarate CA Jr, Payne JL, Quiroz J, et al: An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 2004; 161:171-174
67. Zarate CA Jr, Quiroz JA, Singh JB, et al: An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry 2005; 57: 430-432
68. Zarate CA Jr, Singh JB, Carlson PJ, et al: A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63:856-864
69. Bench CJ, Frackowiak RS, Dolan RJ: Changes in regional cerebral blood flow on recovery from depression. Psychol Med 1995; 25: 247-261
70. Barbas H, Hilgetag CC, Saha S, et al: Parallel organization of contralateral and ipsilateral prefrontal cortical projections in the rhesus monkey. BMC Neurosci 2005; 6:32
71. Guehl D, Benazzouz A, Aouizerate B, et al: Neuronal correlates of obsessions in the caudate nucleus. Biol Psychiatry 2008; 63: 557-562
72. Bae JN, MacFall JR, Krishnan KR, et al: Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. Biol Psychiatry 2006; 60:1356-1363
73. Alexopoulos GS, Kiosses DN, Choi SJ, et al: Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am J Psychiatry 2002; 159:1929-1932
74. Taylor WD, MacFall JR, Payne ME, et al: Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. Am J Psychiatry 2004; 161:1293-1296
75. Shimony JS, Sheline YI, D'Angelo G, et al: Diffuse microstructural abnormalities of normal-appearing white matter in late life depression: a diffusion tensor imaging study. Biol Psychiatry 2009; 66:245-252
76. Hannestad J, Taylor WD, McQuoid DR, et al: White matter lesion volumes and caudate volumes in late-life depression. Int J Geriatr Psychiatry 2006; 21:1193-1198
77. Fazekas F, Kleinert R, Offenbacher H, et al: Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43:1683-1689
78. Pantoni L, Garcia JH: Pathogenesis of leukoaraiosis: a review. Stroke 1997; 28:652-659
79. Thomas AJ, Perry R, Kalaria RN, et al: Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. Int J Geriatr Psychiatry 2003; 18:7-13
80. Thomas AJ, O'Brien JT, Davis S, et al: Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry 2002; 59:785-792
81. Thomas AJ, Ferrier IN, Kalaria RN, et al: A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry 2001; 70:83-87
82. Thomas AJ, Ferrier IN, Kalaria RN, et al: Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. Am J Psychiatry 2000; 157: 1682-1684
83. Thomas AJ, Davis S, Morris C, et al: Increase in interleukin-1beta in late-life depression. Am J Psychiatry 2005; 162:175-177
84. Thomas AJ, Ferrier IN, Kalaria RN, et al: Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly. Br J Psychiatry 2002; 181:129-134
85. Miguel-Hidalgo JJ, Overholser JC, Jurjus GJ, et al: Vascular and extravascular immunoreactivity for intercellular adhesion molecule 1 in the orbitofrontal cortex of subjects with major depression: age-dependent changes. J Affect Disord 2011; 132: 422-431
86. Khundakar A, Morris C, Slade J, et al: Examination of glucose transporter-1, transforming growth factor-beta and neuroglobin immunoreactivity in the orbitofrontal cortex in late-life depression. Psychiatry Clin Neurosci 2011; 65:158-164
87. Xekardaki A, Santos M, Hof P, et al: Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden. Acta Neuropathol 2012; 124:453-464
88. Tsopelas C, Stewart R, Savva GM, et al: Neuropathological correlates of late-life depression in older people. Br J Psychiatry 2011; 198:109-114
89. Miguel-Hidalgo JJ, Jiang W, Konick L, et al: Morphometric analysis of vascular pathology in the orbitofrontal cortex of older subjects with major depression [published online ahead of print December 3, 2012]. Int J Geriatr Psychiatry doi: 10/1002/gps.3911
90. Duman RS, Monteggia LM: A neurotrophic model for stressrelated mood disorders. Biol Psychiatry 2006; 59:1116-1127
91. Douillard-Guilloux G, Guilloux JP, Lewis DA, et al: Anticipated brain molecular aging in major depression. Am J Geriatr Psychiatry 2013; 21:450-460
92. Driscoll I, Martin B, An Y, et al: Plasma BDNF is associated with agerelated white matter atrophy but not with cognitive function in older, non-demented adults. PloS One 2012; 7:e35217
93. Khundakar AA, Zetterstrom TS: Effects of GABAB ligands alone and in combination with paroxetine on hippocampal BDNF gene expression. Eur J Pharmacol 2011; 671:33-38
94. Zafra F, Castren E, Thoenen H, et al: Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Sci USA 1991; 88:10037-10041
95. Matsumoto T, Numakawa T, Yokomaku D, et al: Brain-derived neurotrophic factor-induced potentiation of glutamate and GABA release: different dependency on signaling pathways and neuronal activity. Mol Cell Neurosci 2006; 31:70-84